title: High, intermittent dose of all-trans retinoic acid in combination with alpha-interferon for advanced multiple myeloma.
authors.forename: J
authors.initials: J
authors.lastname: Juturi
authors.forename: R A
authors.initials: RA
authors.lastname: Bukowski
authors.forename: K
authors.initials: K
authors.lastname: Bocock
authors.forename: T
authors.initials: T
authors.lastname: Bloom
authors.forename: J
authors.initials: J
authors.lastname: Finke
authors.forename: M A
authors.initials: MA
authors.lastname: Hussein
mesh_terms: D000328:Adult; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000633:toxicity; D005260:Female; D006801:Humans; D016898:Interferon-alpha / Q000008:administration & dosage* / Q000633:toxicity; D008297:Male; D008875:Middle Aged; D009101:Multiple Myeloma / Q000150:complications / Q000188:drug therapy*; D016879:Salvage Therapy; D017211:Treatment Failure; D014212:Tretinoin / Q000008:administration & dosage* / Q000633:toxicity
chemical_list: D016898:Interferon-alpha; D014212:Tretinoin